000			03446nam a22003735i 4500
001			320221
003			MX-SnUAN
005			20160429161406.0
007			cr nn 008mamaa
008			160111s2015 gw | s |||| 0|eng d
020			_a9783319173894 _9978-3-319-17389-4
035			_avtls000420689
039		9	_y201601110950 _zstaff
050		4	_aRC86-88.9
245	1	0	_aAcute nephrology for the critical care physician / _cedited by Heleen M. Oudemans-van Straaten, Lui G. Forni, A.B. Johan Groeneveld, Sean M. Bagshaw, Michael Joannidis.
264		1	_aCham : _bSpringer International Publishing : _bSpringer, _c2015.
300			_aviii, 286 páginas : _b22 ilustraciones, 19 ilustraciones en color.
336			_atexto _btxt _2rdacontent
337			_acomputadora _bc _2rdamedia
338			_arecurso en línea _bcr _2rdacarrier
347			_aarchivo de texto _bPDF _2rda
500			_aSpringer eBooks
505	0		_a1. Acute Kidney Injury (AKI): Definitions and clinical context (Z. Ricci) -- 2. Epidemiology of AKI (E. Hoste) -- 3. Pathophysiology of AKI: Ischemia/reperfusion, Sepsis/inflammation, Toxicity, Vascular (A.B.J. Groeneveld,) -- 4. Diagnostic work-up of the patient with suspected AKI: Oliguria, Metabolic acidosis (J. Prowle) -- 5. Uremic toxins (R. Vanholder) -- 6. The kidney and other organs/conditions: Heart, Cardiorenal syndromes, Uremic pericarditis, Lungs/Asthma renale, Liver/Hepatorenal syndrome, Gut/Uremic mucositis/GI permeability, Brain, Coagulation, Pregnancy (S. Bagshaw) -- 7. Biomarkers for AKI (M. Ostermann) -- 8. Prevention of AKI and protection of the kidney: Fluids, Vasopressors, Inotropes and vasodilators, Anti-inflammatory treatment, Antioxidants; Prevention of contrast associate nephropathy (M. Joannidis, co-authors ICM paper) -- 9. Timing of renal replacement therapy (RRT) in AKI (S. Bagshaw,) -- 10. Dosing of RRT (C.S.C. Bouman) -- 11. Types of RRT: Continuous vs. intermittent, Convection vs. diffusion, Predilution vs. Postdilution, SLED, Replacement fluids, Membranes, Biocompatability (L.G. Forni) -- 12. Anticoagulation for RRT: Heparin, Citrate, HIT (H.M. Oudemans) -- 13. Metabolic aspects of continuous renal replacement therapy (CRRT): Control of acidosis, Control of electrolytes, Bioenergetic gain and loss, Loss of (micro)nutrient, Nutrition (O. Joannes Boyeau) -- 14. CRRT: in sepsis, after cardiac surgery (P. Honore) -- 15. CRRT in the pediatric population (Z. Ricci) -- 16. Drug removal by CRRT and drug dosing in the patient on CRRT (M. Schetz) -- 17. CRRT for intoxications (D. Cruz) -- 18. How to avoid harm in the patient with AKI: summary of key points of previous chapters (H.M. Oudemans) -- 19. Follow-up and long-term renal outcomes of patients surviving AKI (J. Prowle).
590			_aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700	1		_aOudemans-van Straaten, Heleen M, _eeditor. _9364787
700	1		_aForni, Lui G, _eeditor. _9364788
700	1		_aGroeneveld, A.B. Johan, _eeditor. _9364789
700	1		_aBagshaw, Sean M, _eeditor. _9364790
700	1		_aJoannidis, Michael, _eeditor. _9364791
710	2		_aSpringerLink (Servicio en línea) _9299170
776	0	8	_iEdición impresa: _z9783319173887
856	4	0	_uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-3-319-17389-4 _zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942			_c14
999			_c320221 _d320221